Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 1, 1999, Pages 79-81

  Shaunak, S ^a,b   Wilkins, A ^a   Pilling, J B ^a   Dick, D J ^a  

^a NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Ergot; Parkinson's disease; Pergolide; Serosal fibrosis

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MALE; MEDICAL LITERATURE; PARKINSON DISEASE; PERICARDIAL DISEASE; PLEURA DISEASE; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SYMPTOM; TIME;

EID: 0033065106     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.1.79     Document Type: Article

References (10)

1. Ward C, Thompson J, Humby M. Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment. J Neurol Neurosurg Psychiatry 1987;50:1706-7.
2. Bowler J, Ormerod I, Legg N. Retroperitoneal fibrosis and bromocriptine. Lancet 1986;ii:466.
3. Saura J, Aguilar M, Alio J. Pleural effusion and pericarditis secondary to bromocriptine treatment. Neurologica 1991;6: 331-3.
4. Rinne U. Pleuropulmonary changes during long term bromocriptine treatment for Parkinson's disease. Lancet 1981;i:44.
5. Benard A, Guenanen H, Tillie-Leblond I, et al. Drug induced pleurisy. Rev Mal Resp 1996;13:227-34.
6. Geminiani G, Fetoni V, Genitrini S, et al. Cabergoline in Parkinson's disease complicated by motor fluctuations. Mov Disord 1996;11:495-500.
7. Jiminez-Jiminez F, Lopez-Alvarez J, Sanchez-Chapado M, et al. Retroperitoneal fibrosis in a patient treated with pergolide. Clin Neuropharm 1995;18:277-9.
8. Sanchez-Chapado M, Angulo-Cuesta J, Guil-Cid M, et al. Retroperitoneal fibrosis secondary to treatment with L-Dopa analogues for Parkinson's disease. Arch Esp Urol 1995;48:979-83.
9. Hoffmann W, Trippel O. Retroperitoneal fibrosis: aetiological considerations. J Urol 1961;86:222-32.
10. Iversen B, Nordahl E, Thunold S, et al. Retroperitoneal fibrosis during treatment with L-Dopa. Lancet 1975;ii: 303-4.